MedPath
FDA Approval

Morphine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 11, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Morphine(30 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Morphine Sulfate

Product Details

NDC Product Code
54868-4973
Application Number
NDA022207
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
January 11, 2012
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 30 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT

Morphine Sulfate

Product Details

NDC Product Code
54868-3191
Application Number
NDA022207
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
January 11, 2012
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 15 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
© Copyright 2025. All Rights Reserved by MedPath